Management of Graft-Versus-Host Disease in Hematopoietic Cell Transplant Recipients
GvHD is a potentially serious complication that significantly impacts quality of life in patients undergoing allogeneic HCT. Treatment of GvHD can be optimized by providing coordinated care involving a multidisciplinary team preferably in medical centers which have access to specialized GvHD clinics. Oncology practitioners require ongoing education for the optimal management of patients with GvHD.
Category
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Updates in the Management of Myelofibrosis
As data on novel therapies emerge, it is essential that clinicians are aware of recent developments so they can best evaluate the needs of the patients and select an optimal therapeutic strategy with the goal of improving clinical outcomes.
Category
  • Myeloproliferative Neoplasms
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Management of Waldenström Macroglobulinemia
The treatment armamentarium for WM/LPL continues to grow, and the selection of therapy for initial management of patients with symptomatic WM depends on age, the severity of symptoms, presence of comorbidities, and patient preferences.
Category
Format
  • Recorded Webcast
Credits
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™
This program features updates to the NCCN Guidelines®; new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies, including acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia
Category
Format
Credits
Archived Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix
The management of cervical cancer specific to histology, stage, and setting has changed tremendously and a review of new/latest data is important and helpful for the practitioners in treatment decision-making. Clinicians can benefit from continued education on comparing treatment options to best manage different histological types of cervical cancer.
Category
  • Cervical Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024
These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.
Category
  • Cervical Cancer
Format
  • Monograph/Journal Supplement
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Archived Monthly Oncology Tumor Boards: Management of Advanced Ovarian Cancer
Due to the rapidly changing treatment landscape, clinicians in the community who treat advanced ovarian cancer may not be aware of new data. In order to optimize clinical outcomes, it is crucial for clinicians to be educated on this topic to ensure that they select the most appropriate treatment options for their patients with ovarian cancer.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
May 2023 BCOP Test - Changing Treatment Paradigms in Chronic Lymphocytic Leukemia
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
May 2023 BCOP Test - The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
June 2023 BCOP Test - Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits

Pages